KEEPsAKE-1 and KEEPsAKE-2 studies demonstrated significant improvements in Skyrizi-treated patients
News
The Health Research Authority launches fast-track service for non-COVID-19 research
Service will accelerate the ethics review stage of clinical trials approval
EU approves Moderna’s COVID-19 vaccine
Vaccine is also currently being reviewed in the UK
EU authorises intramuscular administration of Biogen’s Plegridy for MS
New administration option for relapsing-remitting MS patients
Allergy Therapeutics launches biomarker study of peanut allergy vaccine candidate
Study will take place at Imperial College London
US priority review for Forxiga in chronic kidney disease
AZ is aiming for approval in adults with and without type 2 diabetes
University of Birmingham researchers develop rapid COVID-19 RNA test
Test can give accurate results in under five minutes, according to researchers
Angelini Pharma acquires CNS specialist Arvelle Therapeutics
Key focus of the deal is focal-onset seizure treatment cenobamate
EMA launches review of BMS’ Opdivo for oesophageal cancer
Company is aiming for approval in the adjuvant setting
AstraZeneca completes Atacand divestment to Cheplapharm
The total value of all payments for the Atacand brand is $400m
NICE collaboration creates new route for medicines approval
New Innovative Licensing and Access Pathway launched
Pfizer’s Lorbrena scores US priority review
Drug is being reviewed for ALK-positive lung cancer
CRUK scientists develop drug that targets KRAS pathways
KRAS mutations are found in several hard-to-treat cancers
Janssen files EGFR-targeting antibody amivantamab with EMA
Submission based on results from phase I CHRYSALIS study
AstraZeneca/Oxford University’s COVID-19 vaccine set for UK rollout
Shot was approved by MHRA on 30 December
